Cerebrospinal fluid interleukin-10 may be a useful biomarker for atypical primary central nervous system lymphoma relapse.

Cerebrospinal fluid interleukin-10 may be a useful biomarker for atypical primary central nervous system lymphoma relapse. Rev Neurol (Paris). 2020 Nov 12;: Authors: Autier L, Le Garff-Tavernier M, Mathon B, Martin-Duverneuil N, Hoang-Xuan K, Houillier C PMID: 33190919 [PubMed - as supplied by publisher]
Source: Revue Neurologique - Category: Neurology Tags: Rev Neurol (Paris) Source Type: research